Literature DB >> 15465641

Hot-compressed-water decomposed products from bamboo manifest a selective cytotoxicity against acute lymphoblastic leukemia cells.

Hiroki Ando1, Hideki Ohba, Tsuyoshi Sakaki, Kazunori Takamine, Yoshitaka Kamino, Sawako Moriwaki, Rumiana Bakalova, Yoshimitsu Uemura, Yasuo Hatate.   

Abstract

We examined the effect of hot-compressed-water (HCW) extracted and fractionated bamboo products (named as fractions A and B) on the viability of human cultured cell lines, derived from leukemia patients and human peripheral blood lymphocytes, obtained from normal adults. Fraction A was composed of xylose, xylooligosaccharides and water-soluble lignin, determined by high-performance anion exchange chromatography and spectrophotometry. Fraction B was composed of glucose and celooligosaccharides. It was found that Fraction B expressed a negligible cytotoxic effect against leukemia cells, while Fraction A reduced markedly (in a dose-dependent manner) the viability of leukemia cell lines, derived from acute lymphoblastic leukemia (ALL)--Jurkat and MOLT-4. Fraction A did not influence the viability of leukemia cells, derived from myelogenous leukemia (ML-2) or lymphoma (SupT-1), as well as the viability of normal lymphocytes. Furthermore, microscopic examination of ALL-derived cells treated with Fraction A showed typical apoptotic morphological changes such as a condensation of nucleus and membrane blebing, as well as phosphatidylserine (PSer) exposure on the cell surface. The effect of decomposed products of commercially available xylan against ALL-derived Jurkat cells was significantly lower than that of Fraction A. These results suggest that the cytotoxic effect of Fraction A may be attributed to apoptosis, induced by xylooligosaccharides and it is specific for ALL-derived cells. We speculate that the water-soluble lignin is an important factor, potentiating the cytotoxic effect of xylan in HCW-extracts from bamboo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465641     DOI: 10.1016/j.tiv.2004.03.011

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

1.  Delineating thermophilic xylanase from Bacillus licheniformis DM5 towards its potential application in xylooligosaccharides production.

Authors:  Arabinda Ghosh; Saikat Sutradhar; Debabrat Baishya
Journal:  World J Microbiol Biotechnol       Date:  2019-01-31       Impact factor: 3.312

2.  In vitro antioxidant, anticoagulant and antimicrobial activity and in inhibition of cancer cell proliferation by xylan extracted from corn cobs.

Authors:  Raniere Fagundes Melo-Silveira; Gabriel Pereira Fidelis; Mariana Santana Santos Pereira Costa; Cinthia Beatrice Silva Telles; Nednaldo Dantas-Santos; Susana de Oliveira Elias; Vanessa Bley Ribeiro; Afonso Luis Barth; Alexandre José Macedo; Edda Lisboa Leite; Hugo Alexandre Oliveira Rocha
Journal:  Int J Mol Sci       Date:  2011-12-29       Impact factor: 5.923

3.  Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines.

Authors:  Bundit Promraksa; Jutarop Phetcharaburanin; Nisana Namwat; Anchalee Techasen; Patcharee Boonsiri; Watcharin Loilome
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

4.  Combined Treatments Consisting of Calcium Hydroxide and Activate Carbon for Purification of Xylo-Oligosaccharides of Pre-Hydrolysis Liquor.

Authors:  Feng Xu; Jiachuan Chen; Guihua Yang; Xingxiang Ji; Qiang Wang; Shanshan Liu; Yonghao Ni
Journal:  Polymers (Basel)       Date:  2019-09-25       Impact factor: 4.329

Review 5.  The preparation technology and application of xylo-oligosaccharide as prebiotics in different fields: A review.

Authors:  Caoxing Huang; Yuxin Yu; Zheng Li; Bowen Yan; Wenhui Pei; Hao Wu
Journal:  Front Nutr       Date:  2022-08-25

6.  Protective effects of Zhuyeqing liquor on the immune function of normal and immunosuppressed mice in vivo.

Authors:  Hong-ying Gao; Guo-yu Li; Jian Huang; Ying Han; Fu-zhou Sun; Xiao-wei Du; Li-juan An; Hang-yu Wang; Jin-hui Wang
Journal:  BMC Complement Altern Med       Date:  2013-10-03       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.